Hong Kong, China vs Kenya: Previously treated cases tested for RR-/MDR-TB
Hong Kong, China
87.0%
in 2024
Kenya
87.0%
in 2024
Hong Kong, China rank
92nd
Kenya rank
92nd
Previously treated cases tested for RR-/MDR-TB over time
- Hong Kong, China
- Kenya
How they compare
Hong Kong, China currently reports 87.0% against 87.0% in Kenya, a difference of 0.0%.
The two have swapped places 7 times across 18 shared years of data; in 2005 it was Hong Kong, China ahead.
Hong Kong, China ranks 92nd and Kenya ranks 92nd of 180 countries.
Hong Kong, China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.8% | 32.0% | 13.8% | Hong Kong, China |
| 2010s | 59.6% | 44.2% | 15.4% | Hong Kong, China |
| 2020s | 87.8% | 77.4% | 10.4% | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Hong Kong, China or Kenya?
- Hong Kong, China, at 87.0% against 87.0% in Kenya as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Hong Kong, China and Kenya?
- 0.0%, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Kenya?
- 18 years are reported by both, from 2005 to 2024.
- How do Hong Kong, China and Kenya rank globally for previously treated cases tested for rr-/mdr-tb?
- Hong Kong, China ranks 92nd and Kenya ranks 92nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.